MIMMI, SELENA
 Distribuzione geografica
Continente #
NA - Nord America 2.586
AS - Asia 1.308
EU - Europa 953
SA - Sud America 185
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 26
OC - Oceania 5
Totale 5.173
Nazione #
US - Stati Uniti d'America 2.473
SG - Singapore 644
IT - Italia 517
CN - Cina 301
BR - Brasile 151
DE - Germania 127
IN - India 105
VN - Vietnam 100
CA - Canada 80
FI - Finlandia 62
SE - Svezia 59
GB - Regno Unito 51
BD - Bangladesh 39
HK - Hong Kong 38
FR - Francia 24
MX - Messico 15
ES - Italia 14
KR - Corea 14
NL - Olanda 14
PL - Polonia 12
ID - Indonesia 11
RU - Federazione Russa 11
ZA - Sudafrica 11
AR - Argentina 10
RO - Romania 10
UA - Ucraina 10
JP - Giappone 9
CZ - Repubblica Ceca 8
CR - Costa Rica 7
CO - Colombia 6
IQ - Iraq 6
PK - Pakistan 6
AT - Austria 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
EC - Ecuador 4
GR - Grecia 4
LT - Lituania 4
NP - Nepal 4
PT - Portogallo 4
SA - Arabia Saudita 4
VE - Venezuela 4
CL - Cile 3
GT - Guatemala 3
IE - Irlanda 3
KZ - Kazakistan 3
MA - Marocco 3
PE - Perù 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PW - Palau 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 5.067
Città #
San Jose 434
Dallas 321
Singapore 273
Ashburn 235
Chandler 164
Santa Clara 108
Munich 92
Catanzaro 84
Council Bluffs 81
Bengaluru 73
Hefei 73
Milan 68
Beijing 63
Princeton 61
Lawrence 59
Turku 48
Ho Chi Minh City 38
Hong Kong 35
Wilmington 32
Ottawa 31
Seattle 31
Los Angeles 30
London 29
Boardman 28
Rome 22
Chicago 21
Des Moines 19
Montreal 18
São Paulo 17
Brooklyn 16
Hanoi 16
Phoenix 16
Taranto 16
Redmond 15
Napoli 14
Helsinki 13
New York 13
Shanghai 13
Naples 10
Toronto 10
Augusta 9
Paris 9
Aversa 8
Buffalo 8
Olomouc 8
Redwood City 8
Foggia 7
Norwalk 7
Reggio Emilia 7
Seoul 7
Amsterdam 6
Guangzhou 6
Haiphong 6
Johannesburg 6
Marano 6
Modena 6
Stockholm 6
Warsaw 6
Atlanta 5
Chennai 5
Florence 5
Frankfurt am Main 5
Hanover 5
Lahore 5
Lamezia Terme 5
Madrid 5
Mexico City 5
Palermo 5
Providence 5
Pune 5
Rio de Janeiro 5
San Francisco 5
Teresina 5
The Dalles 5
Boston 4
Caserta 4
Charlotte 4
Da Nang 4
Denver 4
Edmonton 4
Heidesheim 4
Houston 4
Huế 4
Las Vegas 4
Latina 4
Louisville 4
Padova 4
Reggio Calabria 4
San José 4
Shenzhen 4
Tokyo 4
Târgu Mureş 4
Washington 4
Xi'an 4
Can Tho 3
Chieti 3
Columbus 3
Crosia 3
Derby 3
Dubai 3
Totale 3.044
Nome #
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 161
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 155
A Candidate multi-targeting approach to block the CD98hc oncoprotein 118
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 109
A novel phage display based platform for exosome diversity characterization 105
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 102
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 99
PEPTIDI E LORO USI 98
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 96
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 95
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 94
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 91
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 90
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 90
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 89
Crucial role for IBtk in the survival and maintenance of mature B cells 87
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 87
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 87
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 82
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 81
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 81
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 80
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 80
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 79
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 78
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 76
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 75
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 74
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 73
Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays 71
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 70
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 68
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 68
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 68
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 67
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 66
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 66
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 65
PEPTIDE AND USES THEREO 65
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 65
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 64
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 64
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 63
Phage Display: An Overview in Context to Drug Discovery 63
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 62
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 62
Phage Display: An Overview in Context to Drug Discovery 61
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 60
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 60
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 59
Insights into Thymus Development and Viral Thymic Infections 58
Belantamab mafodotin in multiple myeloma 57
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 56
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 55
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 54
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 54
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 54
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 52
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 52
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 50
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 50
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 48
Peptide-guided targeting of GPR55 for anti-cancer therapy. 48
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 41
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 37
IN VIVO TUMOR TARGETING BY IDIOTYPE-SPECIFIC PEPTIDES 34
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 33
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 33
Isatuximab in multiple myeloma 32
Idiotype-specific peptides as tools for the specific delivery of therapeutic compounds into tumors 32
Peptide-Guided Targeting Of Gpr55 For New Therapeutic Strategies Of Cance 31
Peptide-guided targeting of GPR55 for anti-cancer therapy 29
PTPRJ negatively modulates CD98hc-CD147 complex activity in A549 lung cancer cells 28
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 27
Neurofilament Light Chain from Neuronally Derived Extracellular Vesicles in Differentiating Parkinson's Disease from Essential Tremor with Resting Tremor 20
New frontiers in porcine atrioventricular node decellularization: preserving extracellular matrix architecture for biological scaffolds 13
Emerging biomarkers in liquid biopsy: the small extracellular vesicles 9
A preanalytical quality indicator framework for automated extracellular vesicle separation 9
null 6
null 2
Totale 5.173
Categoria #
all - tutte 41.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022245 0 0 0 56 20 12 15 60 19 34 27 2
2022/2023552 120 26 37 23 50 37 7 53 107 38 41 13
2023/2024304 58 37 31 23 21 63 4 9 6 6 17 29
2024/20251.026 128 37 45 37 96 102 27 25 142 25 145 217
2025/20262.176 148 216 361 214 213 99 262 120 242 137 115 49
2026/2027526 15 88 232 191 0 0 0 0 0 0 0 0
Totale 5.173